‘Bigger than just Covid vaccines’: US drug giant Moderna wants to collaborate with Hong Kong scientists on mRNA technology with local branch

Patrick Bergstedt, Moderna senior vice-president and head of emerging markets, says city subsidiary will focus on introducing mRNA technology in vaccine development, not only for Covid.

Read the original article at South China Morning Post